Keeping Current CME artwork

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

Keeping Current CME

English - November 17, 2023 22:28 - 32 minutes - 47.7 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Communication Strategies With Caregivers Following the Diagnosis of Rett Syndrome
Next Episode: Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?

Credit available for this activity expires: 11/17/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998210?ecd=bdc_podcast_libsyn_mscpedu